1 From the Cardiology Branch, National Heart and Lung Institute, Bethesda, Maryland.
It is commonly believed that vagally-mediated bradycardia predisposes to ventricular fibrillation (VF) during acute myocardial ischemia. Recent experimental studies, however, have shown that bradycardia and vagal stimulation independently raise the threshold for electrically induced VF in the ischemic canine heart. To determine the influence of vagal stimulation on the spontaneous development of VF occurring during acute myocardial ischemia, open-chest dogs with acute coronary occlusion were observed with and without electrical vagal stimulation. When heart rate was allowed to fall, mean time to VF was 14.7 ± 2.1 min (se) in the control dogs (heart rate about 180/min), 23.4 ± 1.9 (P < 0.01) in the dogs with low intensity vagal stimulation (heart rate about 100/min), and 28.6 ± 0.9 (P < 0.001) in dogs with high intensity vagal stimulation (heart rate about 60/min). Only 10% of the control animals survived after 30 min of occlusion compared with 40% (NS) of the dogs with low intensity vagal stimulation and 71% (P < 0.05) of the dogs with high intensity vagal stimulation. Thus, vagal stimulation and bradycardia were associated with a postponement or prevention of VF. In a second series of animals with heart rate maintained constant by right ventricular pacing, vagal stimulation continued to exert a protective effect against the development of VF. Time to VF was increased from 11.0 ± 2.0 min in control animals to 22.6 ± 2.5 in dogs with vagal stimulation (P < 0.005), and percent survival was enhanced (12% in control animals versus 57% in the vagally stimulated group, P < 0.02). Similar results were observed in a third series of dogs in which electrical stimulation was applied to the peripheral ends of the cut cervical vagi. We conclude that vagal stimulation, with or without accompanying bradycardia, reduces the incidence of spontaneous VF in experimental coronary occlusion. Thus, enhanced vagal tone might act to reduce, rather than increase, the risk of arrhythmic death occurring during acute myocardial ischemia in man.
Submitted on November 26, 1974
© 1974 American Heart Association, Inc.
Beneficial Effects of Vagal Stimulation and Bradycardia During Experimental Acute Myocardial Ischemia
Key Words: Acute myocardial infarction • Cholinergic innervation • Ventricular fibrillation • Arrhythmia
Accepted on January 15, 1974
This article has been cited by other articles:
 |
|
 |
|
  A. Ilebekk, M. Eriksen, K. Sevre, T. Aspelin, J.-A. Bjorkman, T. Lyberg, and M. Nordlander Ventricular Fibrillation Induced by Ischemia-Reperfusion Is Not Prevented by the NPY Y2 Receptor Antagonist BIIE0246. Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2006; 11(3): 177 - 183. [Abstract] [PDF]
|
|
|
|
 |
|
 M. J. Wacker, S. R. Best, L. M. Kosloski, C. J. Stachura, R. L. Smoot, C. B. Porter, and J. A. Orr Thromboxane A2-induced arrhythmias in the anesthetized rabbit Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1353 - H1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.J. Reed, C.E. Robertson, and P.S. Addison Heart rate variability measurements and the prediction of ventricular arrhythmias QJM, February 1, 2005; 98(2): 87 - 95. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Manfrini, G. Morgagni, C. Pizzi, F. Fontana, and R. Bugiardini Changes in autonomic nervous system activity: spontaneous versus balloon-induced myocardial ischaemia Eur. Heart J., September 1, 2004; 25(17): 1502 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.N. Singh Increased heart rate as a risk factor for cardiovascular disease Eur. Heart J. Suppl., September 1, 2003; 5(suppl_G): G3 - G9. [Abstract] [PDF]
|
|
|
|
 |
|
 D Patterson, J B C Dick, and A D Struthers Intensive statin treatment improves baroreflex sensitivity: another cardioprotective mechanism for statins? Heart, October 1, 2002; 88(4): 415 - 416. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Dart, X.-J. Du, and B. A Kingwell Gender, sex hormones and autonomic nervous control of the cardiovascular system Cardiovasc Res, February 15, 2002; 53(3): 678 - 687. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Shusterman, B. Aysin, V. Gottipaty, R. Weiss, S. Brode, D. Schwartzman, K. P. Anderson, and for the ESVEM Investigators Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1891 - 1899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. J. Airaksinen, K. U. O. Tahvanainen, D. L. Eckberg, M. J. Niemela, A. Ylitalo, and H. V. Huikuri Arterial baroreflex impairment in patients during acute coronary occlusion J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1641 - 1647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J MacFadyen, C. S Barr, and A. D Struthers Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients Cardiovasc Res, July 1, 1997; 35(1): 30 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Niroomand, C. Weinbrenner, A. Weis, M. Bangert, C. Schwencke, R. Marquetant, T. Beyer, R. H. Strasser, W. Kubler, and B. Rauch Impaired Function of Inhibitory G Proteins During Acute Myocardial Ischemia of Canine Hearts and Its Reversal During Reperfusion and a Second Period of Ischemia : Possible Implications for the Protective Mechanism of Ischemic Preconditioning Circ. Res., May 1, 1995; 76(5): 861 - 870. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Wacker, R. N. Tehrani, R. L. Smoot, and J. A. Orr Thromboxane A2 mimetic evokes a bradycardia mediated by stimulation of cardiac vagal afferent nerves Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H482 - H490. [Abstract] [Full Text] [PDF]
|
|